7th Pulmonary Disease Conference...Respiratory and Pulmonary Medicine October 17-18, 2016 Chicago,...
Transcript of 7th Pulmonary Disease Conference...Respiratory and Pulmonary Medicine October 17-18, 2016 Chicago,...
COPD Conference 2018conferenceseries.com
https://copd.conferenceseries.com/europe/
***For available speaker slots***[email protected]
Tentative Program
October 22-23,2018 | Rome, Italy
InteractiveSessions
KeynoteLectures
Exhibitors B2BMeetings
PlenaryLectures Workshops
7th International Chronic Obstructive Pulmonary Disease Conference
COPD Conference 2018conferenceseries.com
https://copd.conferenceseries.com/europe/
Program at a Glance
Session 1 Session 2
Morning
Session
s
29 Spe
akers for Day 1
General SessionInaugural Address
Keynote Session
Keynote/Plenary Talk 1 (Slot Available)
2nd International Conference & Expo on
Optometry and Vision ScienceSeptember 11-12, 2017 Paris, France
Program at a GlanceDay 1
Keynote/Plenary Talk 2 (Slot Available)
Lunch Break 6 Speakers (20 min) slot avilable
Panel Discussions/Group Photo
5 Speaker (20 min) slot avilable
Keynote/Plenary Talk 3 (Slot Available)
Coffee/Tea Break (Networking)
5 Speaker (20 min) slot avilable
Coffee/Tea Break (Networking)
Even
ing Sessions Lunch Break5 Speaker (20 min) slot avilable
Poster Sessions
Even
ing Sessions
5 Speaker (20 min) slot avilable
NOTE: Program Shedule is subject to change with final allotment of the speaker slotsFor more Details PS: http://optometry.conferenceseries.com
[email protected]| [email protected]
Day 2
Morning
Session
s
Awards & Closing Ceremony
Coffee/Tea Break (Networking)5 Speaker (20 min) slot avilable
30 Spe
akers o
n Day 2
5 Speaker (20 min) slot avilable
Coffee/Tea Break (Networking)
https://copd.conferenceseries.com/europe/e-mail: [email protected]; [email protected]
COPD Conference 2018conferenceseries.com
https://copd.conferenceseries.com/europe/
Conference Highlights• Chronic Obstructive Pulmonary Disease
• COPD Pathogenesis
• Asthma and COPD
• Epidemiology of COPD
• COPD Therapeutics
• COPD Exacerbations
• Types of COPD
• COPD: Sign and Symptoms
• Genetic risk factor of COPD
• Lung cancer
• COPD and Cardiovascular Diseases
• Pulmonary Hypertension
• Pathophysiology of COPD
• Co-Morbidities of COPD
• COPD Complications
• Pulmonary diseases-treatment and therapies
• Pediatric Pulmonary, Critical care and Sleep
• Depression and anxiety in COPD
• Self-Management and Prevention of COPD
• Case Report
For detailed sessions, please visit: https://copd.conferenceseries.com/europe/
Submit your abstract online at: https://copd.conferenceseries.com/europe/abstract-submission.php
Register online: https://copd.conferenceseries.com/europe/registration.php
COPD Conference 2018conferenceseries.com
https://copd.conferenceseries.com/europe/
Glimpses of COPD Conferences
COPD Conference 2018conferenceseries.com
https://copd.conferenceseries.com/europe/
Plan your trip to Rome
Basilica di Santa Maria Maggiore
Forum of Trajan
colosseum
Baths of Caracalla
The Pantheon
536th Conferenceconferenceseries.com
Chronic Obstructive Pulmonary Disease
Scientific Program
July 11-12, 2016 Brisbane, Australia
3rd International Conference on
Conference Series LLC 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA Ph: +1 702 508 5200 Ext: 8033
e-mail: [email protected]; [email protected]
Page 7
Registrations
Quay 2
Day 1 July 11, 2016
Group PhotoSession Introduction
Track 3: Pathophysiology of COPDTrack 5: Drugs Acting on COPDSession Chair: Ping Yang, Mayo Clinic College of Medicine, USASession Co-Chair: Tsuyoshi Shuto, Kumamoto University, JapanTitle: Biological mechanisms of muscle mass loss and cachexia in patients with COPDEsther Barreiro, Research Institute of Hospital del Mar, SpainTitle: The role of the microbiome in COPDPhil Hansbro, University of Newcastle, AustraliaTitle: SEF classification for COPD managementMd Rashidul Hassan, National Institute of Diseases of the Chest & Hospital, Bangladesh
Lunch Break: Workshop on The Biological Role of Extracellular Vesicles in COPD Tsukasa Kadota, The Jikei University School of Medicine, JapanTitle: Comparative assessment of lung inflammation, pulmonary function and emphysema caused by the aerosol from potential reduced risk products and cigarette smoke in mouse models of COPDPatrick Vanscheeuwijck, Philip Morris International R&D, SwitzerlandTitle: The effect of including manual therapy in the management of mild chronic obstructive pulmonary disease: A randomized controlled trialRoger Mark Engel, Macquarie University, AustraliaTitle: Effects of hyperoxia exposure on free radicals accumulation in relation to ultra structural pathological changes of diaphragmAl Said A Haffor, Dar Al Uloom University, Saudi Arabia
Networking & Refreshment BreakWorkshop Pharmacological and genetic approaches determine protease and oxidative stress as exacerbating factors in a mouse model of obstructive lung diseasesTsuyoshi Shuto, Kumamoto University, JapanTitle: Mechanisms of chronic obstructive pulmonary disease and airway smooth muscle remodeling: Potential roles of ABHD2Shoude Jin, The Fourth Hospital of Harbin Medical University, China
Day 2 July 12, 2016
Quay 2Track 4: COPD and Its ComorbiditiesTrack 8 : Developments in COPD Management
Opening Ceremonyconferenceseries.com
Keynote ForumIntroduction
Title: Low physical activity and COPD: Prognosis and handling of this clinical problem Joaquim Gea, Pompeu Fabra University, Spain
Networking & Refreshment Break
Title: Physiological measures and novel sputum biomarkers to distinguish subjects with mild to moderate copd from asymptomatic current smokers, former smokers and never- smokersPatrick Vanscheeuwijck, Philip Morris International R&D, Switzerland
Page 8
Session Chair: Phil Hansbro, University of Newcastle, AustraliaSession Chair: Geertjan Wesseling, Maastricht UMC+, Netherlands
Session IntroductionTitle: COPD and nutritional abnormalitiesJoaquim Gea, Pompeu Fabra University, SpainTitle: Chronic obstructive pulmonary disease (COPD) complicating early-stage lung cancer (LC)Ping Yang, Mayo clinic College of Medicine, USA
Networking & Refreshment BreakTitle: Clustering of comorbidities and implications for secondary careGeertjan Wesseling, Maastricht UMC+, NetherlandsWorkshop on “COPD Basic concept: Understanding the pathophysiology by Simile to convince physicians”Md Rashidul Hassan, National Institute of Diseases of the Chest & Hospital, BangladeshTitle: Effects of ICS in combination with LABA on improving symptoms and lung function in COPD with airway eosinophiliaHiroaki Kume, Kindai University, Japan
Lunch Break: Title: Chronic obstructive pulmonary disease – A study of the relationship between a patient´s feeling of guilt due to their belief of the disease being self-inflictedGunilla Lindqvist, Linnaeus University, SwedenTitle: A new anti-inflammatory therapy for COPDQian Zeng, Medi7 Bentleigh, AustraliaTitle: What we shouldn’t do in COPDGeertjan Wesseling, Maastricht UMC+, NetherlandsTitle: Forgotten comorbidities in COPDRoger Goldstein and Annemarie Lee, West Park Healthcare Centre, Canada
Networking & Refreshment BreakPoster Presentations
COPD-01Title: Plasma uric acid as a protective factor of respiratory dysfunction and emphysema in female mice and human with obstructive pulmonary diseases Haruka Fujikawa, Kumamoto University, Japan
COPD-02Title: GLP-1 receptor agonist exacerbates mucus hyper secretory phenotype in βENaC-transgenic mouse with obstructive lung diseasesHirofumi Nohara, Kumamoto University, Japan
COPD-03Title: Comparing the effectiveness of a home based self-management intervention and an outpatient based pulmonary rehabilitation intervention for patients with COPDHee-Young Song, Yonsei University, South Korea
Awards CeremonyThanks giving & Closing ceremony
Bookmark your dates
July 13-15, 2017 Wellington, Newzealand4th Chronic Obstructive Pulmonary Disease
e-mail: [email protected] Series LLC
2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
Conference Series Ltd.Traian Str., No.61, Constanta 900720,
Romania, Tel: 0805-080048Heathrow Stockley Park Lakeside
House, 1 Furzeground Way, Heathrow, UB11 1BD, United Kingdom
OMICS International6th Floor, North Block, Divyasree
Building, Raidurg Hyderabad, Telangana, INDIA-500032
Tel: [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
Respiratory and Pulmonary MedicineOctober 17-18, 2016 Chicago, USA
2nd International Conference on
Scientific Program
Hosting Organization: Conference Series LLC2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA, Ph: +1-888-843-8169, Fax: +1-650-618-1417, Toll free: +1-800-216-6499
Heathrow Stockley Park Lakeside House, 1 Furzeground Way, Heathrow, UB11 1BD, UK, Tel: +1-800-216-6499Email: [email protected], [email protected]
conferenceseries.com754th Conference
Page 10
Keynote ForumIntroduction
Title: Trends in the use of outcome parameters for respiratory drug researchRobert Lins, SGS Clinical Research, Belgium
Group Photo
Session:Tuberculosis | COPD and Pulmonary Fibrosis
Session Chair: Yimin Qin, Mallinckrodt Pharmaceuticals, USASession Introduction
Title: Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.Toidi Adekambi, Emory University School of Medicine, USA
Networking & RefreshmentTitle: SarcoidosisQin Yimin, Mallinckrodt Pharmaceuticals, USATitle: Prevalence, risk factors and clinical correlates of chronic obstructive pulmonary disease in a rural setting in TanzaniaNgweina Magitta, Ifakara Health Institute, Dar es Salaam, TnazaniaTitle: The role of SIRT1 in LPS-induced lung endothelial barrier dysfunction and lung injury in vivoWeizhong Jin, Hangzhou First People's Hospital-Nanjing Medical University, China
Lunch Break
Session:COPD | Lung disease: AlveoliSession Chair: Yimin Qin, Mallinckrodt Pharmaceuticals, USA
Session IntroductionTitle: Healthcare Resource Utilization and Costs in Sarcoidosis Patients in a Commercially-Insured US PopulationMichael Philbin, Mallinckrodt Pharmaceuticals, USATitle: TuberculosisSamuel Dinkneh, St Peter TB Specialized Hospital, EthiopiaTitle: The value of EBUS in the diagnosis of bronchi Dieulafoy’s diseaseWeizhong Jin, Hangzhou First People's Hospital-Nanjing Medical University, China Title: Coexistence of cystic fibrosis and celiac diseaseSonia Shahid, Abbasi Shaheed Hospital, Karachi
Networking & Refreshment
Poster Presentations 16:30-17:30
P1Title: Predictive multiscale computational tool for simulation of lung absorption and pharmacokinetics and optimization of pulmonary drug delivery
Ravi Kannan, CFD Research Corp, USA
P2Title: Clinical and epidemiological profile of patients with chronic obstructive Camilio Ruiz, Pontifical Bolivarian University, Colombia
P3Title: Design, synthesis and anti-tubercular potential of some new substituted 1,2,4-triazoles derived from isonicotinic acid hydrazidesVarsha Kashaw, Dr Harisingh Gour University, India
P4Title: The dangers of judicious amiodarone use: An unusual case of amiodarone toxicity
Kathryn Tapper, The Mayo Clinic, USA
P5Title: Development of in-silico QSAR models of 1,2,4 oxadiazole derivatives as potential apoptosis inducer and anticancer agents Sushil Kashaw, Wayne State University, USA
P6Title: Depression and its frequency in patients with chronic obstructive pulmonary disease Seyda Seemad Gilani, Clinical Psychologist, USA
RegistrationsDay 1 October 17, 2016
Prague Room
Opening Ceremonyconferenceseries.com
Page 11
Panel Discussion
Day 2 October 18, 2016
Prague RoomKeynote Forum
Title:Reactive Oxygen Species: from Respiratory muscle to the Heart
Li(Alex)Zuo, Ohio State University College of Medicine, USASessions:
Advances in Respiratory Medicine | Cystic Fibrosis | COPD | Tuberculosis | Lung ProblemsSession Chair: Li(Alex)Zuo, Ohio State University College of Medicine, USA
Session IntroductionTitle: Metabolic Syndrome and Pulmonary Arterial Hypertension: the relationship between gut and lungFlavio Pirozzi, Sao Paulo University, Brazil
Networking and RefreshmentTitle: Pre-hospital antiplatelet therapy for the incidence of acute respiratory distress syndrome: A systematic reviewWeizhong Jin, Hangzhou First People's Hospital-Nanjing Medical University, China Title: COPD Due to Sulfur Mustard ExposureHossein Rahmani, Islamic Azad University, IranTitle: Thoracic oncology and Interventional PulmonologyIrfan Budhani, St Elizabeth Health Care, USA
Lunch BreakTitle: Multiple Approaches for COPD Prevention and Treatment via Redox Mechanism Feng He, California State University-Chico, USATitle: ROS mechanism and treatment of asthma in the older populationZewen Liu, Ohio State University College of Medicine, USATitle: Hypoxic Preconditioning Strengthens Diaphragm during Hypoxia via ROS Signaling in COPD MiceLi(Alex)Zuo, Ohio State University College of Medicine, USA
Networking & RefreshmentTitle: The value of EBUS in the diagnosis of bronchi Dieulafoy’s diseaseJaspreet Singh, Gill Baba Farid University of Healthy Sciences, India
Awards & Closing Ceremony
Conference Series LLC2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
Conference Series LtdHeathrow Stockley Park Lakeside
House, 1 Furzeground WayHeathrow, UB11 1BD
United [email protected]
OMICS International6th Floor, North Block
Divyasree Building, Raidurg Hyderabad Telangana, INDIA-500032
Tel: [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
Bookmark Your Dates
Website: www.respiratory.conferenceseries.comE-mail: [email protected]; [email protected]
July 17-19, 2017 Melbourne, AustraliaRespiratory & Pulmonary Medicine3rd International Conference on